Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Im Cannabis | IMCC | Jan 13, 2025 | 2.32 | -4.92 |
IMAC | BACK | Jan 13, 2025 | 1.21 | -4.69 |
IMAX | IMAX | Jan 13, 2025 | 22.81 | -1.13 |
Immatics | IMTX | Jan 13, 2025 | 6.25 | -2.80 |
Immersion | IMMR | Jan 13, 2025 | 8.79 | +5.90 |
Immix Biopharma | IMMX | Jan 13, 2025 | 2.12 | +0.95 |
ImmuCell | ICCC | Jan 13, 2025 | 5.33 | +2.70 |
Immuneering A | IMRX | Jan 13, 2025 | 2.01 | -2.90 |
Immunic | IMUX | Jan 13, 2025 | 1.07 | +1.90 |
ImmunityBio | IBRX | Jan 13, 2025 | 2.48 | +2.48 |
Immunocore ADR | IMCR | Jan 13, 2025 | 30.03 | -1.22 |
Immunome | IMNM | Jan 13, 2025 | 10.04 | -5.28 |
ImmunoPrecise Antibodies | IPA | Jan 13, 2025 | 0.52 | -1.42 |
Immunovant | IMVT | Jan 13, 2025 | 22.75 | -3.11 |
Immutep ADR | IMMP | Jan 13, 2025 | 1.94 | -3.48 |
Imperial Oil | IMO | Jan 13, 2025 | 66.61 | -0.37 |
Imperial Petroleum | IMPP | Jan 13, 2025 | 3.37 | +2.12 |
Imperial Petroleum A Pref | IMPPP | Jan 13, 2025 | 25.00 | 0.00 |
Impinj | PI | Jan 13, 2025 | 146.32 | +1.88 |
Imunon | IMNN | Jan 13, 2025 | 0.92 | +1.80 |
IN8bio | INAB | Jan 13, 2025 | 0.32 | -1.95 |
Inari Medical | NARI | Jan 13, 2025 | 79.34 | +0.06 |
Incannex Healthcare ADR | IXHL | Jan 13, 2025 | 1.80 | -2.70 |
Inception Growth Acquisition | IGTA | Jan 13, 2025 | 11.75 | 0.00 |
Inception Growth Acquisition Unit | IGTAU | Jan 13, 2025 | 12.00 | 0.00 |
Income Opportunity Realty Investors | IOR | Jan 13, 2025 | 18.19 | +0.14 |
Incyte | INCY | Jan 13, 2025 | 72.37 | +2.59 |
Indaptus Therapeutics | INDP | Jan 13, 2025 | 0.95 | -0.02 |
Independence Realty Trust | IRT | Jan 13, 2025 | 18.70 | +2.58 |
Independent Bank | IBCP | Jan 13, 2025 | 32.85 | +0.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.